Filtrer

Type
Date de publication
Langue

Documents Hogrefe publishing 6 résultats

Filtrer
Sélectionner : Tous / Aucun
Q
Déposez votre fichier ici pour le déplacer vers cet enregistrement.
y
- 454 p.
Cote : QV 77.2 C641 2019

Psychotropes - Guides, manuels, etc.

The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.
• Independent, unbiased, up-to-date
• Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
• Succinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
• Potential interactions and side effects summarized in comparison charts
• With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
• Clearly written patient information sheets available for download as printable PDF files

New in this edition
• Antidepressants chapter includes new section on esketamine (Spravato), recently approved for treatment-resistant depression; also updates to antidepressant use in pregnancy and SPARI drug interactions
• Antipsychotics updates include new section on 5-HT2A inverse agonist antipsychotic (pimavanserin, Nuplazid) and comprehensive revision of augmentation strategies
• Pharmacogenomics chapter fully revised with expanded dose adjustment recommendations
• Chart of agents under investigation for treatment of substance use disorders fully revised, new agents include lofexidine (Lucemyra), Kadian, nortriptyline e-cigarettes
• Unapproved treatments chapter with significant updates, including new sections on adrenergic agents in PTSD (doxazosin), antiflammatory agents in depression (pioglitazone, rosiglitazone, statins), and hormones in schizophrenia (raloxifene)
• Expanded treatment options for extrapyramidal side effects include deutetrabenazine and valbenazine
• New formulations and trade names include: Spravato (esketamine), as well as Adzenys ER, Aristada, Austedo, Cotempla XR-ODT, Fanatrex FusePaq, Foquest, Ingrezza, Jornay PM, Mydayis, Nuplazid, Sublocade, Zelapar
This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.

... Lire [+]

Favoris Imprimer
Déposez votre fichier ici pour le déplacer vers cet enregistrement.
y
- vi, 99 p.
Cote : WM 203.5 J83a 2015

Troubles envahissants du développement ; Autisme - Diagnostic

This latest addition to the Advances in Psychotherapy - Evidence-Based Practice series is a straightforward yet authoritative guide to effective diagnosis and empirically supported treatments for autism spectrum disorder (ASD). The book starts by reviewing DSM-5 and ICD-10 diagnostic criteria, current theories and models, and prevalence rates for ASD and related neurodevelopmental disorders. It explains the differences between the disorders and changes in criteria and names (such as Asperger's syndrome, childhood and atypical autism, pervasive developmental disorder, Rett's syndrome) over time. It then provides clear guidance on evaluation of ASD and comorbidities, with practical outlines and examples to guide practice. The core of the book that follows is a clear description of current interventions and their empirical support, including psychosocial, pharmacological, educational, social skills, and complementary/alternative treatments. Clinical vignettes and marginal notes highlighting the key points help make it an easy-to-use resource, incorporating the latest scientific research, that is suitable for all mental health providers dealing with autism spectrum disorder.

... Lire [+]

Favoris Imprimer
Déposez votre fichier ici pour le déplacer vers cet enregistrement.
y
- 362 p. : ill.
Cote : QV 77.2 C640 2014

Psychotropes ; Pharmacologie pédiatrique ; Maladies mentales - Chimiothérapie

Many psychotropic drugs are used to treat childhood and adolescent mental illness on the basis of efficacy in adults, despite not being currently approved for use in the young. The lack of approval does not necessarily reflect lack of safety or efficacy, but it does reflect a lack of controlled studies. The Clinical Handbook of Psychotropic Drugs for Children and Adolescents is a unique resource to help you make the right choice for younger patients :
Independent, unbiased
Unique comparison charts (dosages, side effects, pharmacokinetics, interactions…) that allow you to see at a glance which medication is the most suitable for each patient
Instantly recognizable icons and full color throughout
Compiles the latest information from the published literature (scientific data, controlled clinical trials, case reports) and clinical experience in one easy-to-use reference
Includes monograph statements on use in children and adolescents and approved indications, as well as available data concerning off-label indications, findings from open and double-blind studies concerning doses, adverse effects, and other considerations
Succinct, bulleted information on all classes of medication: classification, available products (including US and Canadian trade names), on- and off-label indications (US FDA and Health Canada); pharmacology, dosing, pharmacokinetics; adverse effects, precautions, contraindications, toxicity; lab tests, precautions, nursing implications; drug interactions; patient and caregiver instructions... All you need to know for each class of drug!Many psychotropic drugs are used to treat childhood and adolescent mental illness on the basis of efficacy in adults, despite not being currently approved for use in the young. The lack of approval does not necessarily reflect lack of safety or efficacy, but it does reflect a lack of controlled studies. The Clinical Handbook of Psychotropic Drugs for Children and Adolescents is a unique resource to help you make the right choice for younger patients :
Independent, unbiased
Unique comparison charts (dosages, side effects, pharmacokinetics, interactions…) that allow you to see at a glance which medication is the most suitable for each patient
Instantly recognizable icons and full color throughout
Compiles the latest information from the published literature (scientific data, controlled clinical trials, case reports) and clinical experience in one easy-to-use reference
Includes monograph statements on use in children and adolescents and approved indications, as well as available data concerning off-label indications, findings from open and double-blind studies concerning doses, adverse effects, and other considerations
Succinct, bulleted information on all classes of medication: classification, available products (including US and Canadian trade names), on- and off-label indications (US FDA and Health Canada); pharmacology, dosing, pharmacokinetics; adverse effects, precautions, contraindications, toxicity; lab tests, precautions, nursing implications; drug interactions; patient and caregiver instructions... All you need to know for each class of drug!

... Lire [+]

Favoris Imprimer
Déposez votre fichier ici pour le déplacer vers cet enregistrement.
y
- vi, 129 p.
Cote : WL 340.2 B423l 2014

Troubles du langage chez l'enfant

Language impairment in childhood and adolescence: presentation, diagnosis, assessment, and empirically validated treatment.

As many as half of children and adolescents presenting for mental health services have language impairments, often undiagnosed. This book offers a clear and comprehensive description of language impairment emerging in childhood and its implications for clinical practice with children and adolescents. The book is filled with many clinical pearls and examples of the way language impairment impacts on the child's symptom picture and influences treatment. After discussing ICD-10 and the new DSM-5 criteria, it provides the reader with an easy-to-follow plan on how to conduct the assessment with the child and parents, and the steps to take in initiating treatment. Unique modifications to empirically validated treatments are recommended for language-impaired children with comorbid anxiety or disruptive behavior disorders. Anyone who works with children and adolescents will benefit from this book.

... Lire [+]

Favoris Imprimer
Déposez votre fichier ici pour le déplacer vers cet enregistrement.
y
- x, 131 p. : ill.
Cote : WM 170 G858p 2013

Phobies chez l'enfant ; Angoisse chez l'enfant ; Angoisse chez l'adolescent

Compact, authoritative guidance to effective assessment and treatment of the most common psychological difficulties in children and adolescents - phobia and anxiety disorders
This authoritative but compact text addresses the psychopathology, assessment, and treatment of the anxiety disorders and phobias in childhood and adolescence. These perplexing conditions are the most prevalent psychological difficulties in young people and result in considerable impairment and distress, not only to the child but also to her or his family. Effective treatments exist, but unfortunately many of these interventions are either not known to the practicing professionals or not used by them. This volume aims to address this gap and to present these interventions in a clear and straightforward manner.

... Lire [+]

Favoris Imprimer
Déposez votre fichier ici pour le déplacer vers cet enregistrement.
y
- 336 p. : ill.
Cote : WB 104 K59a 2011

Médecine et psychologie ; Relations personnel médical-patient ; Médecine clinique ; Médecine intégrative

Technological innovations and new drugs have led to an explosion in the costs of medical care, and also to the realization among both medical and allied practitioners and patients that such innovation has not necessarily led to more effective care. A gap exists between theory and real-life practice one that this book attempts to bridge.

Thought-provoking essays by an array of distinguished contributors, based on contemporary research and wide-ranging experience in clinical practice, show how we can and must go beyond pure technology in order to improve clinical care. Cultural and social factors on the part of the patients; the practitioner s own personality and other soft factors ; society trends such as increased migration; communication skills; techniques ranging from mindfulness, cognitive psychology, and narrative medicine, to humor. All these and other human factors that medical professionals and those in training (physicians, nurses, counselors, and others) need to integrate into practice to provide effective and cost-effective care are explored and illuminated here by leading experts from a variety of disciplines.

... Lire [+]

Favoris Imprimer